STAT Plus: Supreme Court deals a series of blows to generic drug companies
It’s a bad run for generic drug companies at the Supreme Court.
The court on Monday denied three separate requests from generic drug makers hoping the justices would revisit lower-court decisions the industry doesn’t like.
Continue to STAT Plus to read the full story…
Read Original Article: STAT Plus: Supreme Court deals a series of blows to generic drug companies »
